![Matt Budoff](/-/media/Non-Clinical/Images/System-Images/Profile-Images/B/Budoff_Matt.png)
General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Esperion(SIGNIFICANT) SPEAKER'S BUREAU: Amarin(SIGNIFICANT), Amgen(SIGNIFICANT), Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: General Electric(SIGNIFICANT)